Grifols announced that in order to simplify and improve clarity in the presentation of its financial information, the company will reduce the number of measures used to reflect EBITDA in its earnings reports to two: consolidated EBITDA on a profit and loss basis and consolidated adjusted EBITDA. Grifols added that it will limit the use of non-recurring, infrequent or unusual items to specific cases, providing details and justification for the use of such items. With regard to adjustments for cost savings, operational improvements, and synergies made to consolidated EBITDA under its credit agreement, Grifols confirmed that this financial measure is not used as an alternative measure of entity performance and should, therefore, not be interpreted as such. “In reference to the report published by the Spanish National Securities Market Commission on 21 March 2024, Grifols presents in this report the information requested and wishes to state its full commitment to comply with all regulations and standards in force to guarantee the transparency and integrity of present and future financial information,” the company said in a statement.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRFS:
- Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening
- Grifols says CNMV validates financial statements, indebtedness of Grifols
- Grifols sees addressing 2025 maturities ‘efficiently’ in first half of 2024
- Largest borrow rate increases among liquid names
- Grifols downgraded to Sell at Deutsche Bank on ‘problem’ of cash flow guidance